Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where John Leslie Atwell is active.

Publication


Featured researches published by John Leslie Atwell.


Molecular Immunology | 1996

Design and expression of a stable bispecific scFv dimer with affinity for both glycophorin and N9 neuraminidase

John Leslie Atwell; Lesley A. Pearce; Maria Lah; L. Clem Gruen; Alexander A. Kortt; Peter J. Hudson

We have designed and produced a stable bispecific scFv dimer (bisFv) by non-covalent association of two hybrid VH-VL pairs derived from an anti-neuraminidase antibody (NC10) and an anti-glycophorin antibody (1C3). The bisFv dimer was demonstrated to have binding activity to the two respective target antigens and was evaluated as a reagent for rapid whole blood agglutination assays. The bisFv was expressed in the periplasm of Escherichia coli, from a secretion vector which comprised two cistrons in tandem under the control of a single lac promoter, inducible with IPTG. Each cistron encoded one of the hybrid VH-VL pairs, with V domains separated by a linker region encoding the five amino acids, Gly4Ser. The short linker region was designed to prevent association of VH and VL regions of the same molecule and favour the formation of dimers. The protein synthesized from each hybrid scFv cistron was directed to the E. coli periplasm by the inclusion of distinctive signal secretion sequences preceding each hybrid gene; from pel B of Erwinia cartovora and from gene III of fd phage. The bisFv was affinity-purified from culture supernatants via the C-terminal tag epitope FLAG and was shown, by FPLC on a Superose 6 column, to be consistent in size with that of a scFv dimer. The bisFv was stable for more than 4 months at 4 degrees C and was shown by BIAcore analysis to bind to either target antigen, human glycophorin, or tern N9 neuraminidase. Simultaneous binding to both target antigens was demonstrated when a pre-formed bisFv-neuraminidase complex was shown to bind to immobilized glycophorin. In whole blood agglutination assays, the bisFv dimer was able to agglutinate red blood cells when crosslinked with an anti-idiotype antibody (3-2G12) binding to the NC10 combining site, but no agglutination occurred on binding the antigen neuraminidase. These results are a function of the topology of the epitopes on neuraminidase and have implications for the use of relatively rigid bifunctional molecules (as bisFv dimers) to cross link two large membrane-anchored moieties, in this case, red blood cell glycophorin and neuraminidase, an M(r) 190,000 tetramer.


Protein Engineering | 1997

Single-chain Fv fragments of anti-neuraminidase antibody NC10 containing five- and ten-residue linkers form dimers and with zero-residue linker a trimer

A A Kortt; M Lah; G W Oddie; C L Gruen; J E Burns; Lesley A. Pearce; John Leslie Atwell; Airlie J. McCoy; G J Howlett; D W Metzger; R G Webster; Peter J. Hudson


Archive | 1998

High avidity polyvalent and polyspecific reagents

Peter John Hudson; Alex Andrew Kortt; Robert Alexander Irving; John Leslie Atwell


Protein Engineering | 1999

scFv multimers of the anti-neuraminidase antibody NC10: length of the linker between VH and VL domains dictates precisely the transition between diabodies and triabodies.

John Leslie Atwell; Kerry A. Breheney; Lynne J. Lawrence; Airlie J. McCoy; Alexander A. Kortt; Peter J. Hudson


Archive | 1993

Target binding polypeptide

Peter John Hudson; Maria Lah; Alex Andrew Kortt; Robert Alexander Irving; John Leslie Atwell; Robyn Louise Malby; Barbara E. Power; Peter M. Colman


Archive | 1993

Target binding polypeptide comprising an IG-like VL domain linked to an IG-like VH domain

John Leslie Atwell; Peter M. Colman; Peter John Hudson; Robert Alexander Irving; Alex Andrew Kortt; Maria Lah; Robyn Louise Malby; Barbara E. Power


Archive | 1998

Polyvalent à forte avidité et réactifs poly-spécifiques

Peter John Hudson; Alex Andrew Kortt; Robert Alexander Irving; John Leslie Atwell


Archive | 1998

Reactifs polyvalents presentant une avidite elevee et une specificite multiple

Peter John Hudson; Alex Andrew Kortt; Robert Alexander Irving; John Leslie Atwell


Archive | 1998

Hochbegehrtes Polyvalent und polyspezifische Reagenzien

Peter John Hudson; Alex Andrew Kortt; Robert Alexander Irving; John Leslie Atwell


Archive | 1998

Polyvalente und polyspezifische reagentienmit hoher avidität Polyvalent and polyspecific reagentienmit high avidity

Peter John Hudson; Alex Andrew Kortt; Robert Alexander Irving; John Leslie Atwell

Collaboration


Dive into the John Leslie Atwell's collaboration.

Top Co-Authors

Avatar

Robert Alexander Irving

Commonwealth Scientific and Industrial Research Organisation

View shared research outputs
Top Co-Authors

Avatar

Maria Lah

Commonwealth Scientific and Industrial Research Organisation

View shared research outputs
Top Co-Authors

Avatar

Barbara E. Power

Commonwealth Scientific and Industrial Research Organisation

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Robyn Louise Malby

Walter and Eliza Hall Institute of Medical Research

View shared research outputs
Top Co-Authors

Avatar

Peter J. Hudson

Commonwealth Scientific and Industrial Research Organisation

View shared research outputs
Top Co-Authors

Avatar

Alexander A. Kortt

Commonwealth Scientific and Industrial Research Organisation

View shared research outputs
Top Co-Authors

Avatar

Lesley A. Pearce

Commonwealth Scientific and Industrial Research Organisation

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

A A Kortt

University of Melbourne

View shared research outputs
Researchain Logo
Decentralizing Knowledge